Luca Bianchi

11.4k total citations
389 papers, 5.8k citations indexed

About

Luca Bianchi is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Luca Bianchi has authored 389 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Dermatology, 144 papers in Immunology and 84 papers in Epidemiology. Recurrent topics in Luca Bianchi's work include Psoriasis: Treatment and Pathogenesis (120 papers), Dermatology and Skin Diseases (80 papers) and Nonmelanoma Skin Cancer Studies (41 papers). Luca Bianchi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (120 papers), Dermatology and Skin Diseases (80 papers) and Nonmelanoma Skin Cancer Studies (41 papers). Luca Bianchi collaborates with scholars based in Italy, United States and Germany. Luca Bianchi's co-authors include Elena Campione, Marina Talamonti, Marco Galluzzo, Augusto Orlandi, Sergio Chimenti, Laura Corte, S. D’Adamio, Roberta Gaziano, Giancarlo Pepeu and Caterina Lanna and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and The Science of The Total Environment.

In The Last Decade

Luca Bianchi

363 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Bianchi Italy 36 2.1k 1.9k 997 908 722 389 5.8k
Kenji Takamori Japan 42 2.5k 1.2× 1.2k 0.6× 2.0k 2.0× 570 0.6× 1.0k 1.4× 256 6.9k
Hidetoshi Takahashi Japan 45 1.2k 0.6× 1.1k 0.6× 1.6k 1.6× 407 0.4× 386 0.5× 266 6.1k
John C. Ansel United States 48 1.9k 0.9× 2.2k 1.2× 1.6k 1.6× 326 0.4× 909 1.3× 81 7.1k
Duraisamy Kempuraj United States 45 604 0.3× 2.5k 1.3× 1.6k 1.6× 556 0.6× 1.5k 2.1× 146 7.5k
Norman Klopp Germany 37 983 0.5× 940 0.5× 2.1k 2.1× 454 0.5× 1.1k 1.6× 97 5.7k
Hans F. Merk Germany 53 3.9k 1.9× 1.4k 0.8× 1.4k 1.4× 591 0.7× 1.3k 1.8× 344 10.2k
Sam Shuster United Kingdom 46 3.7k 1.8× 1.0k 0.5× 990 1.0× 1.3k 1.5× 614 0.9× 365 8.2k
William Boucher United States 35 618 0.3× 1.8k 1.0× 624 0.6× 321 0.4× 835 1.2× 79 4.2k
Wen‐Hung Chung Taiwan 52 1.9k 0.9× 1.8k 1.0× 1.6k 1.6× 944 1.0× 863 1.2× 238 11.3k
Theodora M. Mauro United States 49 2.9k 1.4× 566 0.3× 2.0k 2.0× 261 0.3× 505 0.7× 124 6.4k

Countries citing papers authored by Luca Bianchi

Since Specialization
Citations

This map shows the geographic impact of Luca Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Bianchi more than expected).

Fields of papers citing papers by Luca Bianchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Bianchi. The network helps show where Luca Bianchi may publish in the future.

Co-authorship network of co-authors of Luca Bianchi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Bianchi. A scholar is included among the top collaborators of Luca Bianchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Bianchi. Luca Bianchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Talamonti, Marina, et al.. (2025). Effects of Guselkumab on the FIB ‐4 Index in Psoriasis Patients ( EGIPT ): A Three‐Year Study. The Journal of Dermatology. 52(6). 1113–1117.
4.
5.
Talamonti, Marina, et al.. (2024). Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study. Journal of Clinical Medicine. 13(7). 1876–1876. 4 indexed citations
6.
Raimondo, Cosimo Di, et al.. (2024). Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. International Journal of Molecular Sciences. 25(13). 7099–7099. 2 indexed citations
7.
Raimondo, Cosimo Di, et al.. (2023). The Diagnosis and Management of Cutaneous Metastases from Melanoma. International Journal of Molecular Sciences. 24(19). 14535–14535. 13 indexed citations
8.
Campione, Elena, Marco Galluzzo, Caterina Lanna, et al.. (2023). A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients. Pharmaceuticals. 16(4). 526–526. 16 indexed citations
9.
Cintoni, Marco, Pauline Raoul, Elena Leonardi, et al.. (2023). Metabolic Disorders and Psoriasis: Exploring the Role of Nutritional Interventions. Nutrients. 15(18). 3876–3876. 15 indexed citations
10.
Talamonti, Marina, et al.. (2021). Quality of Life and Psychological Impact in Patients with Atopic Dermatitis. Journal of Clinical Medicine. 10(6). 1298–1298. 36 indexed citations
11.
Ribero, Simone, Gabriella Fabbrocini, Vincenzo Bettoli, et al.. (2021). Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting. Journal of the European Academy of Dermatology and Venereology. 35(7). e441–e442. 39 indexed citations
12.
Pampena, Riccardo, Valeria Manfreda, Αthanassios Kyrgidis, et al.. (2020). Digital dermoscopic changes during follow‐up of de‐novo and nevus‐associated melanoma: a cohort study. International Journal of Dermatology. 59(7). 813–821. 7 indexed citations
13.
Galluzzo, Marco, et al.. (2020). Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study. Journal of Clinical Medicine. 9(7). 2170–2170. 58 indexed citations
14.
Caputo, Valerio, Claudia Strafella, Andrea Termine, et al.. (2020). RNAseq-Based Prioritization Revealed COL6A5, COL8A1, COL10A1 and MIR146A as Common and Differential Susceptibility Biomarkers for Psoriasis and Psoriatic Arthritis: Confirmation from Genotyping Analysis of 1417 Italian Subjects. International Journal of Molecular Sciences. 21(8). 2740–2740. 16 indexed citations
15.
Galluzzo, Marco, S. D’Adamio, Maria Sole Chimenti, et al.. (2019). Successful treatment of psoriatic crumbly nails with ustekinumab. Dermatologic Therapy. 32(3). e12914–e12914. 4 indexed citations
16.
Gaziano, Roberta, Elena Campione, Federico Iacovelli, et al.. (2018). Antifungal activity of <em>Cardiospermum halicacabum</em> L. (Sapindaceae) against <em>Trichophyton rubrum</em> occurs through molecular interaction with fungal Hsp90. Drug Design Development and Therapy. Volume 12. 2185–2193. 20 indexed citations
17.
Dattola, Annunziata, et al.. (2017). Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis. Photomedicine and Laser Surgery. 35(9). 484–491. 12 indexed citations
18.
Meier, Ute‐Christiane, Tove Christensen, Daniel R. Altmann, et al.. (2016). Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study biomarker outcome results. UCL Discovery (University College London). 1 indexed citations
19.
Allasia, Walter, et al.. (2016). SALVEREMO, an automatic system for the search and rescue in the wilderness and mountain areas. EGUGA. 1 indexed citations
20.
Franceschini, Chiara, et al.. (2016). The Quality of Life impairment in Hidradenitis Suppurativa. CINECA IRIS Institutial research information system (University of Pisa). 151. 37–43. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Takamori Breakdown of academic impact, for papers by Hidetoshi Takahashi Breakdown of academic impact, for papers by John C. Ansel Breakdown of academic impact, for papers by Duraisamy Kempuraj Breakdown of academic impact, for papers by Norman Klopp Breakdown of academic impact, for papers by Hans F. Merk Breakdown of academic impact, for papers by Sam Shuster Breakdown of academic impact, for papers by William Boucher Breakdown of academic impact, for papers by Wen‐Hung Chung Breakdown of academic impact, for papers by Theodora M. Mauro
Rankless by CCL
2026